Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant

Nadia El Mrimar1,2, El Mehdi Belouad1,2, Elmostafa Benaissa1,2

  • 11Research Team of Epidemiology and Bacterial Resistance, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.

Insights

Pandrug-resistant Acinetobacter baumannii strains are increasing globally. This study identified novel mutations in colistin resistance genes of two clinical isolates, highlighting the multifactorial nature of antibiotic resistance.

Area of Science:

  • Microbiology
  • Genetics
  • Infectious Diseases

Background:

  • Pandrug-resistant Acinetobacter baumannii poses a significant global health threat.
  • Colistin resistance in A. baumannii is often linked to alterations in lipid A or the pmrAB two-component system.

Purpose of the Study:

  • To investigate the genetic basis of colistin resistance in two clinical isolates of A. baumannii (ABRC1 and ABRC2).
  • To identify novel mutations associated with extreme colistin resistance.

Main Methods:

  • Isolating and characterizing two A. baumannii strains (ABRC1, ABRC2) with high colistin resistance (MIC >256 mg/L).
  • Utilizing PCR and sequencing to analyze colistin resistance genes (pmrA, pmrB, lpxA, lpxC, lpxD, lpsB).
  • Comparing obtained sequences with reference strains (ATCC 19606, 17987).

Main Results:

  • Both strains exhibited novel mutations: N287D in lpxC and E117K in lpxD.
  • ABRC1 showed an additional H200L mutation in pmrA.
  • Both strains shared an A138T mutation in pmrB, and ABRC2 had an R263S substitution in its histidine kinase domain.
  • Three mutations (Q216K, H218G, S219E) were identified in the lpsB gene of both strains.

Conclusions:

  • Colistin resistance in A. baumannii is a complex, multifactorial trait.
  • Novel mutations in lpxC, lpxD, pmrA, pmrB, and lpsB contribute to extreme colistin resistance in clinical isolates.
  • These findings enhance our understanding of antibiotic resistance mechanisms in A. baumannii.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...